While DYRK1A affects the cell cycle state of neurons and plays an essential role in neurogenesis8, it was also found to regulate cyclin-dependent kinase-1 (CDK1) activity in glioblastoma cells and DYRK1A inhibition exhibit anti-tumor effects in glioblastoma9,10. This evidence concerns the gene CDK1 and neoplasm.